Access the full text.
Sign up today, get DeepDyve free for 14 days.
HY Chong, SL Teoh, DB-C Wu, S Kotirum, C-F Chiou, N. Chaiyakunapruk (2016)
Global economic burden of schizophrenia: a systematic reviewNeuropsychiatr Dis Treat., 12
RC Gur, JD Ragland, PJ Moberg (2001)
Computerized neurocognitive scanning: II. The profile of schizophreniaNeuropsychopharmacology., 25
RC Young, JT Biggs, VE Ziegler, DA. Meyer (1978)
A rating scale for mania: reliability, validity and sensitivityBr J Psychiatry., 133
LJ Seidman, EC Meyer, AJ Giuliano (2012)
Auditory working memory impairments in individuals at familial high risk for schizophreniaNeuropsychology., 26
Z Wang, SA Meda, MS Keshavan (2015)
Large-scale fusion of gray matter and resting-state functional MRI reveals common and distinct biological markers across the psychosis spectrum in the B-SNIP cohortFront Psychiatry., 6
MF Glasser, SN Sotiropoulos, JA Wilson (2013)
The minimal preprocessing pipelines for the human connectome projectNeuroimage., 80
DM Gardner, AL Murphy, H O’Donnell, F Centorrino, RJ. Baldessarini (2010)
International consensus study of antipsychotic dosingAm J Psychiatry., 167
S Leucht, M Samara, S Heres, JM. Davis (2016)
Dose equivalents for antipsychotic drugs: the DDD methodSchizophr Bull., 42
American Psychiatric Association (2013)
Diagnostic and Statistical Manual of Mental Disorders
S Leucht, M Samara, S Heres (2015)
Dose equivalents for second-generation antipsychotic drugs: the classical mean dose methodSchizophr Bull., 41
K Joyce, A Thompson, S. Marwaha (2016)
Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature reviewInt J Bipolar Disord., 4
GP Strauss, WR Keller, RW Buchanan (2012)
Next-generation negative symptom assessment for clinical trials: validation of the brief negative symptom scaleSchizophr Res., 142
E. Maxwell (1992)
The Family Interview for Genetic Studies Manual
S Leucht, M Samara, S Heres, MX Patel, SW Woods, JM. Davis (2014)
Dose equivalents for second-generation antipsychotics: the minimum effective dose methodSchizophr Bull., 40
JT Baker, AJ Holmes, GA Masters (2014)
Disruption of cortical association networks in schizophrenia and psychotic bipolar disorderJAMA Psychiatry., 71
S Cetin Karayumak, S Bouix, L Ning (2019)
Retrospective harmonization of multi-site diffusion MRI data acquired with different acquisition parametersNeuroimage., 184
SA Montgomery, M. Asberg (1979)
A new depression scale designed to be sensitive to changeBr J Psychiatry., 134
K Kasai, ME Shenton, DF Salisbury (2003)
Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging studyArch Gen Psychiatry., 60
DC Van Essen, SM Smith, DM Barch, TEJ Behrens, E Yacoub, K Ugurbil (2013)
The WU-Minn human connectome project: an overviewNeuroimage., 80
JS Elam, MF Glasser, MP Harms (2021)
The human connectome project: a retrospectiveNeuroimage., 244
WP Horan, AM Kring, RE Gur, SP Reise, JJ. Blanchard (2011)
Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS)Schizophr Res., 132
RJ Drake, N Husain, M Marshall (2020)
Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling studyLancet Psychiatry., 7
A Vita, L De Peri, G Deste, E. Sacchetti (2012)
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studiesTransl Psychiatry., 2
KR Laurens, L Luo, SL Matheson (2015)
Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychosesBMC Psychiatry., 15
M Parellada, S Gomez-Vallejo, M Burdeus, C. Arango (2017)
Developmental differences between schizophrenia and bipolar disorderSchizophr Bull., 43
RJ Hodes, TR Insel, SC Landis (2013)
The NIH toolbox: setting a standard for biomedical researchNeurology., 80
HE Hulshoff Pol, RS. Kahn (2008)
What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophreniaSchizophr Bull., 34
(1994)
Diagnostic and Statistical Manual of Mental Disorders
NC Andreasen, P Nopoulos, V Magnotta, R Pierson, S Ziebell, B-C. Ho (2011)
Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophreniaBiol Psychiatry., 70
A Calvo, G Delvecchio, AC Altamura, JC Soares, P. Brambilla (2019)
Gray matter differences between affective and non-affective first episode psychosis: a review of magnetic resonance imaging studiesJ Affect Disord., 243
K Kasai, ME Shenton, DF Salisbury (2003)
Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosisArch Gen Psychiatry., 60
N Koutsouleris, L Kambeitz-Ilankovic, S Ruhrmann (2018)
Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: a multimodal, multisite machine learning analysisJAMA Psychiatry., 75
CA Tamminga, EI Ivleva, MS Keshavan (2013)
Clinical phenotypes of psychosis in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP)Am J Psychiatry., 170
D. Wechsler (2011)
Wechsler Abbreviated Scale of Intelligence-Second Edition (WASI-II)
AB. Hollingshead (1957)
Two Factor Index of Social Position
W. Berrettini (2003)
Evidence for shared susceptibility in bipolar disorder and schizophreniaAm J Med Genet C Semin Med Genet., 123C
KE Lewandowski, S Bouix, D Ongur, ME. Shenton (2020)
Neuroprogression across the early course of psychosisJ Psychiatr Brain Sci., 5
B Crespo-Facorro, P Such, A-G Nylander (2021)
The burden of disease in early schizophrenia—a systematic literature reviewCurr Med Res Opin., 37
SR Kay, A Fiszbein, LA. Opler (1987)
The positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull., 13
S. McDonald (2014)
Special series on the cognition battery of the NIH toolboxJ Int Neuropsychol Soc., 20
ER Walker, RE McGee, BG. Druss (2015)
Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysisJAMA Psychiatry., 72
OD Howes, T Whitehurst, E Shatalina (2021)
The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysisWorld Psychiatry., 20
C Forbes, JJ Blanchard, M Bennett, WP Horan, A Kring, R. Gur (2010)
Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS)Schizophr Res., 124
TJ Whitford, SM Grieve, TFD Farrow (2006)
Progressive grey matter atrophy over the first 2–3 years of illness in first-episode schizophrenia: a tensor-based morphometry studyNeuroimage., 32
JG Malcolm, ME Shenton, Y. Rathi (2010)
Filtered multitensor tractographyIEEE Trans Med Imaging., 29
RC Gur, J Richard, P Hughett (2010)
A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validationJ Neurosci Methods., 187
DS Marcus, TR Olsen, M Ramaratnam, RL. Buckner (2007)
The extensible neuroimaging archive toolkit: an informatics platform for managing, exploring, and sharing neuroimaging dataNeuroinformatics., 5
B Kirkpatrick, GP Strauss, L Nguyen (2011)
The brief negative symptom scale: psychometric propertiesSchizophr Bull., 37
LT Betz, N Penzel, L Kambeitz-Ilankovic (2020)
General psychopathology links burden of recent life events and psychotic symptoms in a network approachNpj Schizophr., 6
SL James, D Abate, KH Abate (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017Lancet., 392
BA Clementz, RL Trotti, GD Pearlson (2020)
Testing psychosis phenotypes from bipolar-schizophrenia network for intermediate phenotypes for clinical application: biotype characteristics and targetsBiol Psychiatry Cogn Neurosci Neuroimaging., 5
JM Kane, DG Robinson, NR Schooler (2016)
Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment programAm J Psychiatry., 173
N Niv, AN Cohen, G Sullivan, AS. Young (2007)
The MIRECC version of the Global Assessment of Functioning scale: reliability and validityPsychiatr Serv., 58
NL Sohler, J Walkup, D McAlpine, C Boyer, M. Olfson (2003)
Antipsychotic dosage at hospital discharge and outcomes among persons with schizophreniaPsychiatr Serv., 54
LJ Seidman, HC Breiter, JM Goodman (1998)
A functional magnetic resonance imaging study of auditory vigilance with low and high information processing demandsNeuropsychology., 12
AM Kring, RE Gur, JJ Blanchard, WP Horan, SP. Reise (2013)
The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validationAm J Psychiatry., 170
A McCleery, KH. Nuechterlein (2019)
Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerationsDialogues Clin Neurosci., 21
RC Gershon, MV Wagster, HC Hendrie, NA Fox, KF Cook, CJ. Nowinski (2013)
NIH toolbox for assessment of neurological and behavioral functionNeurology., 80
BackgroundThe time following a recent onset of psychosis is a critical period during which intervention may be maximally effective. Studying individuals in this period also offers an opportunity to investigate putative brain biomarkers of illness prior to the long-term effects of chronicity and medication. The Human Connectome Project for Early Psychosis (HCP-EP) was funded by the National Institutes of Mental Health (NIMH) as an extension of the original Human Connectome Project’s approach to understanding the human brain and its structural and functional connections.DesignThe HCP-EP data were collected at 3 sites in Massachusetts (Beth Israel Deaconess Medical Center, McLean Hospital, and Massachusetts General Hospital), and one site in Indiana (Indiana University). Brigham and Women’s Hospital served as the data coordination center and as an imaging site.ResultsThe HCP-EP dataset includes high-quality clinical, cognitive, functional, neuroimaging, and blood specimen data acquired from 303 individuals between the ages of 16–35 years old with affective psychosis (n = 75), non-affective psychosis (n = 148), and healthy controls (n = 80). Participants with early psychosis were within 5 years of illness onset (mean duration = 1.9 years, standard deviation = 1.4 years). All data and novel or modified analytic tools developed as part of the study are publicly available to the research community through the NIMH Data Archive (NDA) or GitHub (https://github.com/pnlbwh).ConclusionsThis paper provides an overview of the specific HCP-EP procedures, assessments, and protocols, as well as a brief characterization of the study participants to make it easier for researchers to use this rich dataset. Although we focus here on discussing and comparing affective and non-affective psychosis groups, the HCP-EP dataset also provides sufficient information for investigators to group participants differently.
Schizophrenia Bulletin – Oxford University Press
Published: Jul 20, 2024
Keywords: neuroimaging; schizophrenia; bipolar disorder; diffusion; resting-state fMRI; cognition
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.